Clinical Trials Browser

OTHER × In Situ Hybridization, Fluorescence × Gastrointestinal × Clear all

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Carcinoma, Squamous Cell, Melanoma, Multiple Myeloma, Myeloproliferative Disorders, Ovarian Neoplasms, Pancreatic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00655499 2021-09-21

PIMABI

Phase 2 Completed

65 enrolled 18 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00550628 2015-12-23

Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer

Completed

8 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00900094 2012-02-07

IRB 2000-294

Completed

200 enrolled

BreastGastrointestinalGynecologicThoracic

Adenocarcinoma Of Esophagus, Carcinoma, Ovarian Epithelial, Esophageal Squamous Cell Carcinoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT00491140 2008-10-01

Retrospective Study Assessing Molecular Features Predicting Response to Cetuximab

Completed

85 enrolled

Gastrointestinal

Colorectal Neoplasms

Clinical Trials

IT-TCP POS

PIMABI

Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer

IRB 2000-294

Retrospective Study Assessing Molecular Features Predicting Response to Cetuximab